Acquisition of Investment Securities and Recognition of Valuation Losses
First written in FY2023-Q2. 4 of 9 entries say "Worsened", first in FY2025. Latest entry: FY2027-H1.
Pr Times moved to the "Worse" side of this theme in 2025.
0 other companies' latest entry also says "Mitigated".
- FY2027-H1MitigatedAnnual report
「Losses on valuation of investment securities 27,463 －」
Losses on valuation of investment securities of ¥27.463 million were recognized in the same interim period of the previous year, but none were recognized in the current interim consolidated accounting period. - FY2026WorsenedAnnual report
「In the consolidated fiscal year, impairment losses of ¥117.469 million were recognized on securities (¥117.469 million in shares classified as other securities).」
Losses on valuation of investment securities increased to ¥117.469 million from ¥110.066 million in the previous fiscal year. - 2026-04-13WorsenedRevision of earnings forecasts
「Impairment loss on investment securities: 110,066; 117,469」
投資有価証券評価損は前連結会計年度の110,066千円から117,469千円へ増加した。 - FY2026-H1WorsenedAnnual report
「Losses on valuation of investment securities － 27,463」
Losses on valuation of investment securities of ¥27.463 million were recognized in the interim consolidated accounting period. Cash outflows of ¥70.006 million also arose from the acquisition of investment securities. - FY2025WorsenedAnnual report
「In the consolidated fiscal year, impairment losses of ¥110.066 million were recognized on securities (¥110.066 million in shares classified as other securities).」
Losses on valuation of investment securities increased to ¥110.066 million from ¥14.625 million in the previous fiscal year. - FY2024AdvancedAnnual report
「Cash used in investing activities was ¥556.068 million, compared with ¥172.183 million used in the previous consolidated fiscal year. This was mainly due to ¥153.583 million of cash used to acquire intangible assets, ¥119.5 million used to acquire investment securities, and ¥192.973 million used to acquire shares of a subsidiary in connection with a change in the scope of consolidation.」
The company recorded ¥119.5 million of cash used to acquire investment securities, and also incurred acquisition costs for Glucose and NAVICUS in investing activities. It also recorded a ¥14.625 million loss on valuation of investment securities. - FY2024-Q2AdvancedAnnual report
「This was mainly due to ¥117.841 million of cash used to acquire intangible assets, ¥50 million used to acquire investment securities, and ¥192.541 million used to acquire shares of a subsidiary in connection with a change in the scope of consolidation.」
During the cumulative second-quarter period, the company recorded ¥50 million of cash used to acquire investment securities. - FY2023AdvancedAnnual report
「Cash used in investing activities was ¥172.183 million, compared with ¥554.691 million used in the previous consolidated fiscal year. This was mainly due to ¥47.517 million of cash used to acquire property, plant and equipment, ¥72.74 million used to acquire intangible assets, ¥99.399 million used to acquire investment securities, and ¥75.263 million of cash received from the recovery of leasehold and guarantee deposits.」
The company disclosed ¥99.399 million of cash used to acquire investment securities and investment securities of ¥75.991 million at the end of the period. It also recorded a ¥49.399 million loss on valuation of investment securities as an extraordinary loss. - FY2023-Q2First statedAnnual report
「Cash used in investing activities was ¥96.427 million, compared with ¥237.834 million used in the same period of the previous year. This was mainly due to ¥99.399 million of cash used to acquire investment securities.」
During the cumulative second-quarter period, the company recorded ¥99.399 million of cash used to acquire investment securities and recorded a ¥49.399 million loss on valuation of investment securities as an extraordinary loss in the quarterly consolidated statement of income.